Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
REGN | B | Regeneron Pharmaceuticals, Inc. | 0.99 | |
MEDP | C | Medpace Holdings, Inc. | -0.17 | |
SRPT | C | Sarepta Therapeutics, Inc. | -0.90 | |
DCTH | C | Delcath Systems, Inc. | 0.63 | |
ORGS | C | Orgenesis Inc. | 4.64 | |
GH | C | Guardant Health, Inc. | 1.20 | |
NBIX | C | Neurocrine Biosciences, Inc. | 0.61 | |
MORF | C | Morphic Holding, Inc. | 0.03 | |
SVRA | C | Savara, Inc. | 2.31 | |
AUPH | C | Aurinia Pharmaceuticals Inc | 2.56 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
XBI | C | SPDR S&P Biotech ETF | 3.76 | |
BTEC | C | Principal Healthcare Innovators Index ETF | 3.05 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 2.91 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 2.64 | |
LABU | C | Direxion Daily S&P Biotech Bull 3X Shares | 2.44 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles